Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
Open Access
- 1 October 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 172 (4) , 1133-1142
- https://doi.org/10.1084/jem.172.4.1133
Abstract
Specific binding sites for human pancreatic secretory trypsin inhibitor (PSTI) on 3T3 Swiss albino cells were studied using radioiodinated recombinant PSTI. Some ion species, pH, and temperature significantly influenced the binding of 125I-PSTI. Kinetic studies showed that the binding of 125I-PSTI to 3T3 Swiss albino cells reached the maximum level within 120 min at 4 degrees C, with a slow dissociation rate. The half-maximal inhibition (ID50) of 125I-PSTI binding by unlabeled PSTI occurred at 1.0 x 10(-10) M. On Scatchard analysis of the competitive binding data, linear plots indicated a single class of receptors with high affinity (Kd = 5.3 x 10(-10) M) on 3T3 Swiss albino cells, the number of receptors being 5,400 per cell. Treatment of surface-bound radiolabeled PSTI with a chemical crosslinker (disuccinimidyl suberate) led to the identification of a membrane polypeptide of Mr 140,000 to which PSTI was crosslinked. The formation was inhibited by an excess amount of unlabeled PSTI in a dose-dependent manner. The binding of 125I-PSTI to 3T3 Swiss albino cells was competitively inhibited by unlabeled PSTI but not by other peptide hormones, such as epidermal growth factor (EGF), bovine fibroblast growth factor, insulin-like growth factor, transforming growth factor alpha, platelet-derived growth factor, and tumor necrosis factor, indicating the presence of receptors specific for PSTI. Various protease inhibitors had no or only a little effect, and mercaptoethanol and dithiothreitol strongly decreased the binding of 125I-PSTI. Incubation at 37 degrees C resulted in rapid internalization of cell-bound 125I-PSTI, followed by the appearance of trichloroacetic acid-soluble 125I-radioactivity in the culture medium, due to degradation of internalized PSTI. In addition, PSTI stimulated [3H]thymidine incorporation into DNA on 3T3 Swiss albino cells in a dose-dependent manner. The combined addition of PSTI and EGF stimulated [3H]thymidine incorporation to an extent greater than that seen with either agent alone. These results indicated that the biological effect of PSTI was mediated by high affinity plasma membrane receptors, which were not a cell-surface proteinase(s). Specific binding of 125I-PSTI was noted with the following cells: WI-38, 3T3 Swiss albino, HUVE, BDC-1, and H4-II-E-C3.This publication has 39 references indexed in Scilit:
- Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissuesFEBS Letters, 1987
- Growth stimulating activity on 3T3 fibroblasts of the molecular weight 6,500-peptide purified from rat pancreatic juiceBiochemical and Biophysical Research Communications, 1986
- Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNABiochemical and Biophysical Research Communications, 1985
- Further evidence for a cell surface proteinase essential to the growth of cultured fibroblastsExperimental Cell Research, 1985
- Conditions which affect initiation of animal cell division by trypsin and thrombinJournal of Cellular Physiology, 1978
- Mitogenicity of thrombin and surface alterations on mouse splenocytesExperimental Cell Research, 1976
- Epidermal growth factor: Internal duplication and probable relationship to pancreatic secretory trypsin inhibitorBiochemical and Biophysical Research Communications, 1974
- Insulin interactions with its receptors: Experimental evidence for negative cooperativityBiochemical and Biophysical Research Communications, 1973
- Radioreceptor Assay for Prolactin and Other Lactogenic HormonesScience, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970